AAII – UTEP AI News Digest home
UTEP · AAIIAI News Digest
Archived digest · Week of Nov 02 - Nov 08, 2026

Applied AI news,
scored for your field

Each week the Institute for Applied AI Innovation reviews AI publications and scores them for Research Relevance, Educational Value, Innovation/Novelty, Practical Impact, Interdisciplinary Potential and Ethical/Policy Implications. Then it writes summaries for each discipline at UTEP.

Read the top 10 →
UTEP Institute for Applied AI Innovation
Weekly AI News Digest
Your Discipline 7 stories

The Week at a Glance

Biological & Biomedical Sciences · Nov 02 - Nov 08, 2026

Biological & Biomedical Sciences. Molecular/cellular biology, biochemistry, epidemiology, toxicology, and biomedical discovery. Prefers translational research and lab-tech updates.
Departments: Biological Sciences, Pharmaceutical Sciences
Key Findings
  • Four new benchmark suites (RareDiseaseBench, BioBasicsBench, BioSecBench‑RespiratoryVirus, TxBench‑Antibody) quantify AI agents’ ability to handle heterogeneous biomedical data and decision points.
  • AI agents demonstrated measurable performance across 21 models and 34 model‑harness configurations on tasks ranging from rare‑disease diagnosis to respiratory virus surveillance.
  • Open‑source models such as CheMeleon (trained on 1 million molecules and 1,600 descriptors) and the Google Antigravity Cheminformatics Skills suite enable accurate property prediction and automated workflow orchestration.
Implications
  • Standardized, task‑specific benchmarks will accelerate the creation of trustworthy, regulatory‑ready AI agents for clinical and research pipelines.
  • Proven ability to integrate wet‑lab evidence suggests AI can shorten experimental cycles, improving speed and reproducibility of discovery.
  • Successes in AI‑guided antibiotic and antibody development point to a future where AI partners are integral to therapeutic innovation, prompting new ethical and oversight frameworks.

Key Metrics

Numbers reported in that week's stories
35Clinically challenging rare‑disease cases in RareDiseaseBench
100Wet‑lab tasks in BioBasicsBench
110AI‑driven respiratory‑virus questions in BioSecBench‑RespiratoryVirus
21Models evaluated across 34 model‑harness configurations
CheMeleon pre‑trained on 1 million molecules and 1,600 chemical descriptors
60Real‑world antibody‑development decisions in TxBench‑Antibody
34Model‑harness configurations tested on TxBench‑Antibody
Weekly summary for Biological & Biomedical Sciences

Biological & Biomedical Sciences

Top articles by AAII Impact Score (out of 30).

Browse the archive ›
No. 1 · Computer Science

RareDiseaseBench: Can AI Agents Diagnose Rare Disease?

Research Computer ScienceBiological SciencesPublic Health Sciences
· 11/06/2026
27/30 AAII Impact Score

AI Summary: The authors introduced RareDiseaseBench, a benchmark of 35 clinically challenging rare‑disease cases that requires AI agents to request and integrate heterogeneous data (genome sequencing, RNA‑seq, imaging, etc.) before producing a diagnosis and management plan. Across 31 model‑harness configurations and 3,255 trial runs, Gemini 4 Argon on the Pi harness achieved the highest preliminary pass rate of 43.8 %, outperforming Opus 5.5 / Claude Code and GPT‑6 Astra / Pi, which reached 33.3 % (the latter at half the compute cost). Performance correlated with model strength and token efficiency, while weaker models frequently failed to request appropriate data or to process large sequencing files efficiently. In total, 29 of the 35 tasks were solved by at least one configuration, with 16 tasks passed in all three attempts by some model.

Topics: Healthcare AIMultimodal AgentRare Disease BenchmarkGenomic Data IntegrationToken Efficiency
AI Rubric Scores
Research Relevance
5
Educational Value
4
Innovation/Novelty
5
Practical Impact
4
Interdisciplinary Potential
5
Ethical/Policy Implications
4
Read the full article ›
No. 2 · Computer Science 26/30

Regina Barzilay and Jim Collins win Pritzker Prize for AI and Science Research Excellence for work in AI-enabled antibiotic discovery

· 11/02/2026
Research Computer SciencePharmaceutical SciencesBiological Sciences

AI Summary: Regina Barzilay and James Collins received the 2026 Pritzker Prize for AI in Science Research Excellence for their joint AI‑enabled antibiotic discovery work. Their 2020 Cell paper introduced halicin, the first antibiotic discovered by deep learning, identified from a model trained on 2,500 molecules and shown to kill multiple drug‑resistant bacteria within weeks. In 2023 they applied the same approach to discover abaucin, a narrow‑spectrum antibiotic effective against Acinetobacter baumannii, reducing resistance risk and preserving gut microbiota. The award highlights the shift from trial‑and‑error to generative AI design in antibiotic research, though the researchers note AI currently automates parts of the pipeline rather than fully transforming drug discovery.

Topics: Healthcare AIDeep Learning Antibiotic DiscoveryGenerative Molecule DesignNarrow‑Spectrum Antibiotic Prediction
No. 3 · Computer Science 26/30

Measuring how AI agents handle everyday wet-lab science

· 11/06/2026
Research Computer ScienceBiological Sciences

AI Summary: BioBasicsBench is a new benchmark, co‑developed with biotech firm Ligo, that evaluates AI agents on 100 wet‑lab tasks requiring interpretation of raw experimental evidence such as gel images, colony plates, microscopy and instrument readouts. The tasks, created from scientists’ own data and reviewed by internal and external experts, test error detection, data interpretation, protocol understanding and the ability to recognize insufficient evidence. At the “xhigh” reasoning setting, GPT‑6 Astra achieved 66.7% of available credit, outperforming GPT‑5.6 Sol’s 43.8%, indicating progress but also highlighting remaining challenges in image analysis, control checking and contextual reasoning.

Topics: Science & ResearchWet‑lab Image InterpretationProtocol ReasoningEvidence Sufficiency Detection
No. 4 · Computer Science 26/30

BioSecBench-RespiratoryVirus-Surveillance: Can AI Agents Track Respiratory Viruses?

· 11/05/2026
Research Computer SciencePublic Health SciencesBiological Sciences

AI Summary: The authors introduced BioSecBench-RespiratoryVirus-Surveillance, a benchmark of 110 AI‑driven questions covering diagnostic assays, pathogen discovery, viral evolution, transmission, and population surveillance. Testing 21 models across 34 model‑harness configurations in 11,220 trials yielded a maximum overall pass rate of 25.5% (Opus 5.5 on Pi), with only 74 of the 110 questions solved by any setup. Population‑surveillance tasks were the most challenging, achieving an average pass rate of 4.3% versus 16.7% for pathogen‑discovery tasks. Model cost did not predict accuracy, as low‑cost runs (e.g., Nemotron 3 Ultra at $0.22 per run) performed comparably to more expensive alternatives.

Topics: Healthcare AIAI Virus SurveillancePathogen Discovery LLMsPopulation Surveillance Benchmark
No. 5 · Computer Science 24/30

How to predict the behavior of molecules from scant data

· 11/06/2026
Research Computer ScienceChemistry & BiochemistryPharmaceutical Sciences

AI Summary: A MIT team introduced CheMeleon, an open‑source machine‑learning model that pre‑trains on one million molecules and 1,600 chemical descriptors to predict diverse properties, including ligand affinities, with limited target‑specific data. The method outperformed existing approaches in selecting promising compounds, as demonstrated in a September 14 paper in the Journal of Chemical Information and Modeling. CheMeleon’s performance led to its frequent use by pharmaceutical companies and its inclusion in nine of the top‑20 entries in the OpenADMET property‑prediction contest. The model is distributed through the ChemProp package, allowing users to fine‑tune it for their own property‑prediction tasks.

Topics: Science & ResearchPretrained Molecular ModelFew‑Shot Property PredictionChemProp Fine‑Tuning
No. 6 · Computer Science 22/30

TxBench–Antibody Development: Can AI Agents Get an Antibody to Its First Human Dose?

· 11/04/2026
Research Computer SciencePharmaceutical SciencesBiological Sciences

AI Summary: The authors introduced TxBench‑Antibody Development, a benchmark comprising 60 real‑world antibody‑development decisions spanning seven stages, each paired with the underlying records and a fixed answer key. They evaluated 34 model‑harness configurations across 6,110 attempts, finding the highest overall pass rate of 39.4 % for Grok 4.7 on Grok Build, with performance dropping to 13 % on toxicology and first‑dose decisions. Although 57 of the 60 decisions were correctly solved by at least one setup, no model achieved high accuracy across all stages, and cost per attempt did not correlate with accuracy.

Topics: Healthcare AIAI Agent BenchmarkAntibody Development ModelingStage-wise Decision Optimization
No. 7 · Computer Science 17/30

Agentic cheminformatics with Google Antigravity

· 11/03/2026
Research Computer ScienceChemistry & BiochemistryPharmaceutical Sciences

AI Summary: The authors released a suite of Cheminformatics Skills for Google Antigravity that integrates RDKit, ChEMBL, and PubChem to automate workflow orchestration, database navigation, and scientific reasoning while delegating molecular calculations to deterministic tools. The system unifies diverse molecular representations—text, images, and data files—enabling collaborative use by computational and experimental chemists without manual data wrangling. A technical walkthrough demonstrates the suite’s application to the medicinal‑chemistry strategy of rigidifying drug molecules, illustrating how cyclization reduces rotatable bonds and improves binding affinity. The case study contrasts the first‑generation inhibitor crizotinib with its rigidified successor lorlatinib, showing the potency gain from eliminating molecular flexibility.

Topics: Healthcare AICheminformatics AutomationMultimodal Molecular RepresentationMolecular Rigidification
Audio Summary
Loading...

Generating...

Weekly Digest Summary

Error.

AI News Chatbot
...
AI

Hello! Ask me anything about this weeks digest.